Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Myeloproliferative disorders: complications, survival and causes of death
2000
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Idiopathic pulmonary fibrosis
2017 Standout
Chronic Myelomonocytic Leukemia: Natural History and Prognostic Determinants
1989
Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications
1994
Long‐term follow‐up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis
2003
Valvular Aortic Stenosis
2006
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Diabetes Mellitus and Heart Failure
2017
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura
2000
Pediatric Pulmonary Hypertension
2013
Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.
1988
Exercise Standards for Testing and Training
2013 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
2008
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure
2002
Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy
2011
Artificial Intelligence in Precision Cardiovascular Medicine
2017 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders
2004
Myocarditis
2011 Standout
Bladder cancer
2016 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Meta-Analysis of Prognostic Value of Stress Testing in Patients With Asymptomatic Severe Aortic Stenosis
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 Standout
Sickle-cell disease
2010 Standout
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Problems in the classification of CMML—dysplastic versus proliferative type
1998
Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases
2007
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients
1994
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia
1999
Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients
2003
Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics
2010
Developing new drugs for the treatment of lymphoma
2005
Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay
2010
Investigational drugs targeting cardiac fibrosis
2013
Thrombotic complications in essential thrombocythemia with relatively low platelet counts
1997
Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes
2005
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Re‐evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases
1990
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
2002
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
5 Myelodysplastic syndromes
1987
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Machine Learning in Medicine
2015 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
2004
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Bioenergetics and translational metabolism: implications for genetics, physiology and precision medicine
2019
Polycythemia vera: myths, mechanisms, and management
2002
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations
2012
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
2013
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Markedly Reduced Expression of Platelet c-mpl Receptor in Essential Thrombocythemia
1997
Works of Marc A. Simon being referenced
Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality
2012
Inotropes in the beta-blocker era
2000
The treatment of adult idiopathic thrombocytopenic purpura
1987
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases
1999
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: A report on 43 cases
1990
Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.
1993
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission
2013
Differential Exercise Performance on Ventricular Assist Device Support
2005
Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease
2014
Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation
2009
Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device
2011
Left Ventricular Remodeling and Myocardial Recovery on Mechanical Circulatory Support
2009
Noninvasive Estimation of Pulmonary Vascular Resistance in Pulmonary Hypertension
2008
Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity
2017
Clinical course of essential thrombocythemia in 147 cases
1990
Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors
1987
Prognostic Importance of Quantitative Exercise Doppler Echocardiography in Asymptomatic Valvular Aortic Stenosis
2005